Japan increases Relenza imports on Tamiflu resistance problems
This article was originally published in Scrip
Executive Summary
Concerns over rising local resistance to Roche/Chugai's Tamiflu (oseltamivir) have led Japan's ministry of health, labour and welfare and GlaxoSmithKline to increase the supply of Relenza (zanamivir) in this major market this flu season.